A Logical Paradigm for Pharmacological Care

Robert Vonk^*
*Correspondence: Robert Vonk, Department of Centre for Health Protection, University of Public Health and the Environment, Bilthoven, The Netherlands, Email:

Introduction

Pharmaceutical care is a patient-centered approach to medication management that aims to improve patient outcomes by optimizing the use of medications. The goal of pharmaceutical care is to ensure that patients receive the right medication, at the right dose, for the right duration and with the right monitoring. Pharmaceutical care is an evolving concept that has gained traction in recent years due to the growing complexity of medication regimens and the increasing number of medications available. It is a collaborative process between pharmacists, other healthcare professionals and patients to optimize medication therapy and improve patient outcomes [1,2].

Description

The concept of pharmaceutical care was first introduced by Hepler and Strand in 1990. They defined pharmaceutical care as “the responsible provision of drug therapy for the purpose of achieving definite outcomes that improve a patient’s quality of life.” This definition emphasizes the importance of outcomes, rather than just the provision of medications. Pharmaceutical care involves several components, including medication therapy management, medication reconciliation, patient education and medication safety. Medication therapy management is a comprehensive approach to medication management that involves assessing the patient’s medication regimen, identifying medicationrelated problems and developing a plan to address these problems. Medication reconciliation is the process of comparing a patient’s medication orders to all Pharmaceutical care is a patient-centered practice that emphasizes the responsible provision of drug therapy for achieving specific therapeutic outcomes. It involves the integration of pharmacists into the healthcare team to optimize medication use, ensure patient safety and improve patient outcomes. This approach to healthcare has gained widespread acceptance in recent years, particularly as the use of prescription medications has increased and become more complex [3].

The practice of pharmaceutical care is focused on the individual patient rather than the disease. It involves the identification and resolution of medicationrelated problems through an ongoing process of assessment, goal setting and monitoring. Pharmacists work closely with other healthcare professionals to ensure that patients receive the most appropriate medications for their needs and that those medications are used safely and effectively. One of the key components of pharmaceutical care is patient education. Pharmacists play an important role in helping patients understand their medications including how to take them, what to expect from them and how to manage any side effects or interactions. This can help to improve adherence to medication regimens, which is essential for achieving optimal therapeutic outcomes [4].

Pharmacists also collaborate with other healthcare providers to ensure that patients receive comprehensive care. This may involve consulting with physicians and other prescribers to ensure that medications are appropriate and safe, or working with nurses and other caregivers to monitor patients for adverse drug reactions or other complications. In addition to providing direct patient care, pharmacists also play an important role in promoting public health. They work to prevent medication errors, monitor drug utilization patterns and provide information and education to the public about the safe and effective use of medications [5].

Conclusion

This can help to reduce healthcare costs, improve health outcomes and prevent unnecessary hospitalizations and other adverse events. Pharmaceutical care has become increasingly important in recent years as the use of prescription medications has increased and become more complex.

Acknowledgement

None.

Conflict of Interest

There are no conflicts of interest by author.

References

1. Lucarelli, Giuseppe, Diego Angelucci, C. Giardini and D. Baronciani, et al. "Fate of iron stores in thalassaemia after bone-marrow transplantation." Lancet 342 (1993): 1388-1391.

Google Scholar, Crossref, Indexed at

2. Kontoghiorghes, George J. "How to manage iron toxicity in post-allogeneic hematopoietic stem cell transplantation?." Expert Rev Hematol 13 (2020): 299-302.

Google Scholar, Crossref, Indexed at

3. Maximova, Natalia, Massimo Gregori, Roberto Simeone and Aurelio Sonzogni, et al. "Safety and tolerability of deferasirox in pediatric hematopoietic stem cell transplant recipients: One facility's five years’ experience of chelation treatment." Oncotarget 8 (2017): 631-637.

Google Scholar, Crossref, Indexed at

4. Phatak, Pradyumna, Pierre Brissot, Mark Wurster and Paul C. Adams, et al. "A phase 1/2, dose‐escalation trial of deferasirox for the treatment of iron overload in HFE‐related hereditary hemochromatosis." Hepatology 52 (2010): 1671-1779.

Google Scholar, Crossref, Indexed at

5. Bring, Penny, Nilufar Partovi, Jo‐Ann E. Ford and Eric Yoshida et al. "Iron overload disorders: Treatment options for patients refractory to or intolerant of phlebotomy." Int J Pharmacol 28 (2008): 331-342.

Google Scholar, Crossref, Indexed at